Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 3, 2015, Pages 715-729

  Mallapragada, Surya K ^a   Brenza, Timothy M ^a   McMillan, JoEllyn M ^b   Narasimhan, Balaji ^a   Sakaguchi, Donald S ^c   Sharma, Anup D ^a   Zbarska, Svitlana ^c   Gendelman, Howard E ^b  

^a Iowa State University   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

Drug development; Nanoformulation; Nanoneuromedicine; Nanotechnology; Targeting

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; DRUG PRODUCTS; MEDICAL NANOTECHNOLOGY; MOBILE SECURITY; NANOTECHNOLOGY;

ANTI-INFLAMMATORIES; BLOOD-BRAIN BARRIER; CELLULAR TECHNOLOGIES; DRUG DEVELOPMENT; ENABLING TECHNOLOGIES; NANOFORMULATION; NANONEUROMEDICINE; TARGETING;

STEM CELLS;

CYANOACRYLATE; NANOFIBER; NANOMATERIAL; NANOPARTICLE; NANOTUBE; POLYANHYDRIDE; POLYESTER; POLYETHER;

AGING; CELL REGENERATION; CENTRAL NERVOUS SYSTEM; DRUG TARGETING; HUMAN; NANOFABRICATION; NANOMEDICINE; NANONEUROMEDICINE; NERVOUS SYSTEM; NEURAL STEM CELL; NONHUMAN; REVIEW; TRANSCYTOSIS; DRUG DELIVERY SYSTEM; METABOLISM; NERVOUS SYSTEM DISEASES; PROCEDURES;

AGING; DRUG DELIVERY SYSTEMS; NANOMEDICINE; NANOSTRUCTURES; NERVOUS SYSTEM DISEASES; NEURAL STEM CELLS;

EID: 84933500494     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.12.013     Document Type: Review

References (192)

1. Gendelman H., Mosley L., Boska M.D., McMillan J. The promise of nanoneuromedicine. Nanomedicine 2014, 9:171-176.
2. Wootla B., Denic A., Warrington A.E., Rodriguez M. Need for a paradigm shift in therapeutic approaches to CNS injury. Expert Rev Neurother 2012, 12:409-420.
3. de Vries H.E., Kooij G., Frenkel D., Georgopoulos S., Monsonego A., Janigro D. Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease. Epilepsia 2012, 53(Suppl. 6):45-52.
4. Frank-Cannon T.C., Alto L.T., McAlpine F.E., Tansey M.G. Does neuroinflammation fan the flame in neurodegenerative diseases?. Mol Neurodegener 2009, 4:47. 10.1186/1750-1326-4-47.
5. Graves D., Vernino S. Immunotherapies in neurologic disorders. Med Clin North Am 2012, 96:497-523.
6. Kanwar J.R., Sriramoju B., Kanwar R.K. Neurological disorders and therapeutics targeted to surmount the blood-brain barrier. Int J Nanomedicine 2012, 7:3259-3278.
7. Rosenberg G.A. Neuroinflammatory disease. IBC meeting on neuroinflammatory disease: research and treatment strategies. London, UK, 17 and 18 September 1996. Mol Med Today 1997, 3:12-13.
8. Elman L.B., Houghton D.J., Wu G.F., Hurtig H.I., Markowitz C.E., McCluskey L. Palliative care in amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. J Palliat Med 2007, 10:433-457.
9. Nowacek A., Kosloski L.M., Gendelman H.E. Neurodegenerative disorders and nanoformulated drug development. Nanomedicine (Lond) 2009, 4:541-555.
10. Imaizumi Y., Okano H. Modeling human neurological disorders with induced pluripotent stem cells. J Neurochem 2014, 129:388-399.
11. Mochizuki H., Choong C.J., Yasuda T. The promises of stem cells: stem cell therapy for movement disorders. Parkinsonism Relat Disord 2014, 20(Suppl. 1):S128-S131.
12. Kang K., Kim M.H., Park M., Choi I.S. Neurons on nanotopographies: behavioral responses and biological implications. J Nanosci Nanotechnol 2014, 14:513-521.
13. Alam M.I., Beg S., Samad A., Baboota S., Kohli K., Ali J., et al. Strategy for effective brain drug delivery. Eur J Pharm Sci 2010, 40:385-403.
14. Kanwar J.R., Sun X., Punj V., Sriramoju B., Mohan R.R., Zhou S.F., et al. Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal. Nanomedicine 2012, 8:399-414.
15. Wang H., Chen X. Applications for site-directed molecular imaging agents coupled with drug delivery potential. Expert Opin Drug Deliv 2009, 6:745-768.
16. Lopac S.K., Torres M.P., Wilson-Welder J.H., Wannemuehler M.J., Narasimhan B. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres. J Biomed Mater Res B Appl Biomater 2009, 91:938-947.
17. Torres M.P., Vogel B.M., Narasimhan B., Mallapragada S.K. Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms. J Biomed Mater Res A 2006, 76:102-110.
18. Kreuter J., Alyautdin R.N., Kharkevich D.A., Ivanov A.A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 1995, 674:171-174.
19. Grislain L., Couvreur P., Lenaerts V., Roland M., Deprez-Decampeneere D., Speiser P. Pharmacokinetics and distribution of a biodegradable drug darrier. Int J Pharm 1983, 15:335-345.
20. Kreuter J., Petrov V.E., Kharkevich D.A., Alyautdin R.N. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles. J Control Release 1997, 49:81-87.
21. Gulyaev A.E., Gelperina S.E., Skidan I.N., Antropov A.S., Kivman G.Y., Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 1999, 16:1564-1569.
22. Steiniger S.C., Kreuter J., Khalansky A.S., Skidan I.N., Bobruskin A.I., Smirnova Z.S., et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 2004, 109:759-767.
23. Alyautdin R.N., Petrov V.E., Langer K., Berthold A., Kharkevich D.A., Kreuter J. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm Res 1997, 14:325-328.
24. Alyautdin R.N., Tezikov E.B., Ramge P., Kharkevich D.A., Begley D.J., Kreuter J. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J Microencapsul 1998, 15:67-74.
25. Alyautdin R., Khalin I., Nafeeza M.I., Haron M.H., Kuznetsov D. Nanoscale drug delivery systems and the blood-brain barrier. Int J Nanomedicine 2014, 9:795-811.
26. Gunatillake P.A., Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 2003, 5:1-16. [discussion 16].
27. Gelperina S., Maksimenko O., Khalansky A., Vanchugova L., Shipulo E., Abbasova K., et al. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. Eur J Pharm Biopharm 2010, 74:157-163.
28. Tosi G., Costantino L., Rivasi F., Ruozi B., Leo E., Vergoni A.V., et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. J Control Release 2007, 122:1-9.
29. Li J., Zhang C., Li J., Fan L., Jiang X., Chen J., et al. Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides. Pharm Res 2013, 30:1813-1823.
30. Rao K.S., Reddy M.K., Horning J.L., Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 2008, 29:4429-4438.
31. Wohlfart S., Khalansky A.S., Gelperina S., Maksimenko O., Bernreuther C., Glatzel M., et al. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One 2011, 6:e19121. 10.1371/journal.pone.0019121.
32. Tamada J.A., Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci U S A 1993, 90:552-556.
33. von Burkersroda F., Schedl L., Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials 2002, 23:4221-4231.
34. Budhian A., Siegel S.J., Winey K.I. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. Int J Pharm 2008, 346:151-159.
35. Kashi T.S., Eskandarion S., Esfandyari-Manesh M., Marashi S.M., Samadi N., Fatemi S.M., et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine 2012, 7:221-234.
36. Musumeci T., Ventura C.A., Giannone I., Ruozi B., Montenegro L., Pignatello R., et al. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 2006, 325:172-179.
37. Wang Y., Challa P., Epstein D.L., Yuan F. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment. Biomaterials 2004, 25:4279-4285.
38. Sadat T., Kashi J., Eskandarion S., Esfandyari-Manesh M., Mahmoud S., Marashi A., et al. Improved drug loading and antibacterial activity on minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine 2012, 7:221-234.
39. Pfeifer B.A., Burdick J.A., Langer R. Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres. Biomaterials 2005, 26:117-124.
40. Determan A.S., Wilson J.H., Kipper M.J., Wannemuehler M.J., Narasimhan B. Protein stability in the presence of polymer degradation products: consequences for controlled release formulations. Biomaterials 2006, 27:3312-3320.
41. Rosen H.B., Chang J., Wnek G.E., Linhardt R.J., Langer R. Bioerodible polyanhydrides for controlled drug delivery. Biomaterials 1983, 4:131-133.
42. Wu M.P., Tamada J.A., Brem H., Langer R. In-Vivo Versus in-Vitro Degradation of Controlled-Release Polymers for Intracranial Surgical Therapy. J Biomed Mater Res 1994, 28:387-395.
43. Howard M.A., Gross A., Grady M.S., Langer R.S., Mathiowitz E., Winn H.R., et al. Intracerebral drug delivery in rats with lesion-induced memory deficits. J Neurosurg 1989, 71:105-112.
44. Brem H., Kader A., Epstein J.I., Tamargo R.J., Domb A., Langer R., et al. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. Sel Cancer Ther 1989, 5:55-65.
45. Jampel H.D., Koya P., Leong K., Quigley H.A. In vitro release of hydrophobic drugs from polyanhydride disks. Ophthalmic Surg 1991, 22:676-680.
46. Lesniak M.S., Upadhyay U., Goodwin R., Tyler B., Brem H. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Cancer Res 2005, 25:3825-3832.
47. Domb A.J., Rock M., Schwartz J., Perkin C., Yipchuk G., Broxup B., et al. Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain. Biomaterials 1994, 15:681-688.
48. Attenello F.J., Mukherjee D., Datoo G., McGirt M.J., Bohan E., Weingart J.D., et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experiance. Ann Surg Oncol 2008, 15:2887-2893.
49. Tabata Y., Langer R. Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds. Pharm Res 1993, 10:391-399.
50. Jain J.P., Modi S., Kumar N. Hydroxy fatty acid based polyanhydride as drug delivery system: synthesis, characterization, in vitro degradation, drug release, and biocompatibility. J Biomed Mater Res 2008, 84A:740-752.
51. Shieh L., Tamada J., Chen I., Pang J., Domb A., Langer R. Erosion of a new family of biodegradable polyanhydrides. J Biomed Mater Res 1994, 28:1465-1475.
52. Gao J., Niklason L., Zhao X.-M., Langer R. Surface modification of polyanhydride microspheres. J Pharm Sci 1998, 87:246-248.
53. Chavez-Santoscoy A.V., Roychoudhury R., Pohl N.L.B., Wannemuehler M.J., Narasimhan B., Ramer-Tait A.E. Tailoring the Immune Response by Targeting C-type Lectin Receptors on Alveolar Macrophages using "Pathogen-like" Amphiphilic Polyanhydride Nanoparticles. Biomaterials 2012, 33:4762-4772.
54. Donbrow M., Samoelov Y. Controlled release of tripelennamine and other drugs dispersed in ethyl cellulose PEG films [proceedings]. J Pharm Pharmacol 1976, (28 Suppl.):23P.
55. Meyskens F.L., Graham V., Chvapil M., Dorr R.T., Alberts D.S., Surwit E.A. A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia. J Natl Cancer Inst 1983, 71:921-925.
56. Kawashima Y., Handa T., Kasai A., Takenaka H., Lin S.Y., Ando Y. Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan. J Pharm Sci 1985, 74:264-268.
57. Ta H.T., Dass C.R., Dunstan D.E. Injectable chitosan hydrogels for localised cancer therapy. J Control Release 2008, 126:205-216.
58. Shamji M.F., Hwang P., Bullock R.W., Adams S.B., Nettles D.L., Setton L.A. Release and activity of anti-TNFalpha therapeutics from injectable chitosan preparations for local drug delivery. J Biomed Mater Res B Appl Biomater 2009, 90:319-326.
59. Ohta T., Tani A., Kimbara K., Kawai F. A novel nicotinoprotein aldehyde dehydrogenase involved in polyethylene glycol degradation. Appl Microbiol Biotechnol 2005, 68:639-646.
60. Kawai F. Microbial degradation of polyethers. Appl Microbiol Biotechnol 2002, 58:30-38.
61. Batrakova E.V., Kabanov A.V. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008, 130:98-106.
62. Karatas H., Aktas Y., Gursoy-Ozdemir Y., Bodur E., Yemisci M., Caban S., et al. A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection. J Neurosci 2009, 29:13761-13769.
63. Kim J.-Y., Choi W.I., Kim Y.H., Tae G. Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier. Biomaterials 2013, 34:1170-1178.
64. Shelke N.B., Aminabhavi T.M. Synthesis and characterization of novel poly (sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine. Int J Pharm 2007, 345:51-58.
65. Hou S., McCauley L.K., Ma P.X. Synthesis and erosion properties of PEG-containing polyanhydrides. Macromol Biosci 2007, 7:620-628.
66. Gao K., Jiang X. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int J Pharm 2006, 310:213-219.
67. Calvo P., Gouritin B., Chacun H., Desmaele D., D'Angelo J., Noel J.-P., et al. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm Res 2001, 18:1157-1166.
68. Ogawara K.-I., Furumoto K., Takakura Y., Hashida M., Higaki K., Kimura T. Surface hydrophobicity of particles is not necessarily the most important determinant in their in vivo disposition after intravenous administration in rats. J Control Release 2001, 77:191-198.
69. Kim H.R., Andrieux K., Gil S., Taverna M., Chacun H., Desmaele D., et al. Translocation of poly(ehtylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis. Biomacromolecules 2007, 8:793-799.
70. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53:283-318.
71. Olivier J.-C. Drug transport to brain with targeted nanoparticles. NeuroRx 2005, 2:108-119.
72. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001, 47:65-81.
73. Kreuter J. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). J Microencapsul 2013, 30:49-54.
74. Graff C.L., Pollack G.M. Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 2005, 94:1187-1195.
75. Shah L., Yadav S., Amiji M. Nanotechnology for CNS delivery of bio-therapeutic agents. Drug Deliv Transl Res 2013, 3:336-351.
76. Voigt N., Henrich-Noack P., Kockentiedt S., Hintz W., Tomas J., Sabel B.A. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles. Eur J Pharm Biopharm 2014, 87:19-29.
77. Lacasse F.X., Filion M.C., Phillips N.C., Escher E., McMullen J.N., Hildgen P. Influence of surface properties at biodegradable microsphere surfaces: Effects on plasma protein adsorption and phagocytosis. Pharm Res 1998, 15:312-317.
78. Romberg B., Hennink W.E., Storm G. Sheddable coatings for long-circulating nanoparticles. Pharm Res 2008, 25:55-71.
79. Zhang X.L., He H.Y., Yen C., Ho W., Lee L.J. A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies. Biomaterials 2008, 29:4253-4259.
80. Wohlfart S., Gelperina S., Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release 2012, 161:264-273.
81. Uchegbu F., Siew A. Nanomedicines and Nanodiagnostics come of Age. J Pharm Sci 2013, 102:305-310.
82. Kreuter J., Shamenkov D., Petrov V., Ramge P., Cychutek K., Koch-Brandt C., et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 2002, 10:317-325.
83. Michaelis K., Hoffmann M.M., Dreis S., Herbert E., Alyautdin R.N., Michaelis M., et al. Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006, 317:1246-1253.
84. Ulbrich K., Hekmatara T., Herbert E., Kreuter J. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm 2009, 71:251-256.
85. Aktas Y., Yemisci M., Andrieux K., Gursoy R.N., Alonso M.J., Fernandez-Megia E., et al. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 2005, 16:1503-1511.
86. Skarlatos S., Yoshikawa T., Pardridge W.M. Transport of [125I]transferrin through the rat blood-brain barrier. Brain Res 1995, 683:164-171.
87. Hu K., Shi Y., Jiang W., Han J., Huang S., Jiang X. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease. Int J Pharm 2011, 415:273-283.
88. Tosi G., Badiali L., Ruozi B., Vergoni A.V., Bondioli L., Ferrari A., et al. Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?. Nanomedicine 2012, 7:365-382.
89. Pan W., Kastin A.J. Entry of EGF into brain is rapid and saturable. Peptides 1999, 20:1091-1098.
90. Gaillard P.J., Visser C.C., de Boer A.G. Targeted delivery across the blood-brain barrier. Expert Opin Drug Deliv 2005, 2:299-309.
91. Ulbrich K., Knobloch T., Kreuter J. Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB). J Drug Target 2011, 19:125-132.
92. Banks W.A., Owen J.B., Erickson M.A. Insulin in the brain: there and back again. Pharmacol Ther 2012, 136:82-93.
93. Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 2010, 37:48-57.
94. Liu L., Venkatraman S.S., Yang Y.-Y., Guo K., Lu J., He B., et al. Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Pept Sci 2008, 90:617-623.
95. Tian X.-H., Wang Z.-G., Meng H., Wang Y.-H., Feng W., Wei F., et al. TAT peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm. Int J Nanomedicine 2013, 8:865-876.
96. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Natl Acad Sci U S A 2000, 97:13003-13008.
97. Rousselle C., Clair P., Smirnova M., Kolesnikov Y., Pasternak G.W., Gac-Breton S., et al. Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy. J Pharmacol Exp Ther 2003, 306:371-376.
98. Tian X.-H., Wei F., Wang T.-X., Wang P., Lin X.-N., Wang J., et al. In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain. Int J Nanomedicine 2012, 7:1031-1041.
99. Guarnieri D., Falanga A., Muscetti O., Tarallo R., Fusco S., Galdiero M., et al. Shuttle-mediated nanoparticle delivery to the blood-brain barrier. Small 2013, 9:853-862.
100. Tosi G., Fano R.A., Bondioli L., Badiali L., Benassi R., Rivasi F., et al. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier. Nanomedicine 2011, 6:423-436.
101. Grabrucker A.M., Garner C.C., Boeckers T.M., Bondioli L., Ruozi B., Forni F., et al. Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons, in vito evidences. PLoS One 2011, 6:e17851. 10.1371/journal.pone.0017851.
102. Afergan E., Epstein H., Dahan R., Koroukhov N., Rohekar K., Danenberg H.D., et al. Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release 2008, 132:84-90.
103. Dou H., Destache C.J., Morehead J.R., Mosley R.L., Boska M.D., Kingsley J., et al. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 2006, 108:2827-2835.
104. Batrakova E.V., Li S., Reynolds A.D., Mosley R.L., Bronich T.K., Kabanov A.V., et al. A macrophage-nanozyme delivery system for Parkinson's disease. Bioconjug Chem 2007, 18:1498-1506.
105. Kanmogne G.D., Singh S., Roy U., Liu X., McMillan J., Gorantla S., et al. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells. Int J Nanomedicine 2012, 7:2373-2388.
106. Zhao Y., Haney M.J., Mahajan V., Reiner B.C., Dunaevsky A., Mosley R.L., et al. Active targeted macrophage-mediated delivery of catalase to affected brain regions in models of Parkinson's disease. J Nanomed Nanotechnol 2011, S4. 10.4172/2157-7439.S4-003.
107. Kreuter J., Shamenkov D., Petrov V., Ramge P., Cychutek K., Koch-Brandt C., et al. Apolipoprotein-mediated transport of nanoparticle-bound drug across the blood-brain barrier. J Drug Target 2002, 10:317-325.
108. Tosi G., Costantino L., Rivasi F., Ruozi B., Leo E., Vergoni A.V., et al. Targeting the central nervous system: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 2007, 122:1-9.
109. Snyder E.Y., Vescovi A.L. The possibilities/perplexities of stem cells. Nat Biotechnol 2000, 18:827-828.
110. Alvarez-Buylla A., Garcia-Verdugo J.M. Neurogenesis in adult subventricular zone. J Neurosci 2002, 22:629-634.
111. Morshead C.M., Reynolds B.A., Craig C.G., McBurney M.W., Staines W.A., Morassutti D., et al. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 1994, 13:1071-1082.
112. Weiss S., Dunne C., Hewson J., Wohl C., Wheatley M., Peterson A.C., et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 1996, 16:7599-7609.
113. Luskin M.B. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 1993, 11:173-189.
114. Lois C., Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 1993, 90:2074-2077.
115. Li L., Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005, 21:605-631.
116. Howk C.L., Levine H.A., Smiley M.W., Mallapragada S.K., Nilsen-Hamilton M., Sakaguchi D. A Mathematical Model for Selective Differentiation of Neural Progenitor Cells on Micropatterned Polymer Substrates. Math Biosci 2012, 238:65-79.
117. Peterson L., Oh J., Sakaguchi D., Mallapragada S.K., Narasimhan B. Amphiphilic Polyanydride Films Promote Neural Stem Cell Adhesion and Differentiation. Tissue Eng 2011, 17:2533-2541.
118. Blong C., Ye E., Jeon C.-J., Oh J., Callahan J.M., Law W.D., et al. Differentiation and Behavior of Human Neural Progenitor Cells on Micropatterned Substrates. J Neurosci Res 2010, 88:1445-1456.
119. Ariza C., McHugh K.P., White S.S., Petruk V., Sakaguchi D., Mallapragada S.K. Extracellualr Matrix Proteins and Astrocyte-Derived Soluble Factors Influence the Differentiation and Proliferation of Neural Progenitor Cells. J Biomed Mater Res 2010, 94A:816-824.
120. Ariza C.A., Fleury A.T., Tormos C.J., Petruk V., Chawla S., Oh J., et al. The influence of electric fields on hippocampal neural progenitor cells. Stem Cell Rev 2010, 6:585-600.
121. Oh J., Recknor J., Mallapragada S.K., Sakaguchi D. Soluble Factors from Neocortical Astrocytes Enhance Neuronal Differentiation of Neural Progenitor Cells from Adult Rat Hippocampus on Polymer Substrates. J Biomed Mater Res A 2009, 91:575-585.
122. Recknor J., Sakaguchi D., Mallapragada S.K. Growth and Differentiation of Neural Progenitor Cells on Micropatterned Polymer Substrates. Biomaterials 2006, 27:4098-4108.
123. Silva-Vargas V., Crouch E.E., Doetsch F. Adult neural stem cells and their niche: a dynamic duo during homeostasis, regeneration, and aging. Curr Opin Neurobiol 2013, 23:935-942.
124. Lee W., Parpura V. Chapter 6 - Carbon nanotubes as substrates/scaffolds for neural cell growth. Prog Brain Res 2009, 180:110-125.
125. Mooney E., Dockery P., Greiser U., Murphy M., Barron V. Carbon nanotubes and mesenchymal stem cells: biocompatibility, proliferation and differentiation. Nano Lett 2008, 8:2137-2143.
126. Sujatha G., Sinha A., Singh S. Cells behaviour in presence of nano-scaffolds. J Biomed Nanotechnol 2011, 7:43-44.
127. Wilson C.J., Clegg R.E., Leavesley D.I., Pearcy M.J. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 2005, 11:1-18.
128. Shao Z.H., Wang P.J., Ni J., Li M.H., Gao X.L., Zhao X.H. In vivo labeling of rat neural progenitor cells in subventricular zone with superparamagnetic iron oxide for tracking of magnetic resonance imaging. Zhonghua Yi Xue Za Zhi 2013, 93:807-810.
129. Chen C-C.V., Ku M-C., D M.J., Lai J-S., Hueng D-Y., Chang C. Simple SPION incubation as an efficient intracellular labeling method for tracking neural progenitor cells using MRI. PLoS One 2013, 8:e56125. 10.1371/journal.pone.0056125.
130. Vande Velde G., Couillard-Despres S., Aigner L., Himmelreich U., van der Linden A. In situ labeling and imaging of endogenous neural stem cell proliferation and migration. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, 4:663-679.
131. Ren Y.J., Zhang S., Mi R., Liu Q., Zeng X., Rao M., et al. Enhanced differentiation of human neural crest stem cells towards the Schwann cell lineage by aligned electrospun fiber matrix. Acta Biomater 2013, 9:7727-7736.
132. Miyoshi S., Flexman J.A., Cross D.J., Maravilla K.R., Kim Y., Anzai Y., et al. Transfection of neuroprogenitor cells with iron nanoparticles for magnetic resonance imaging tracking: cell viability, differentiation, and intracellular localization. Mol Imaging Biol 2005, 7:286-295.
133. Vasita R., Katti D.S. Nanofibers and their applications in tissue engineering. Int J Nanomedicine 2006, 1:15-30.
134. Schiffman J.D., Schauer C.L. A review: Electrospinning of biopolymer nanofibers and their applications. Polym Rev 2008, 48:317-352.
135. Shah S., Yin P.T., Uehara T.M., Chueng S.T., Yang L., Lee K.B. Guiding stem cell differentiation into oligodendrocytes using graphene-nanofiber hybrid scaffolds. Adv Mater 2014, 26:3673-3680.
136. Lim S.H., Liu X.Y., Song H., Yarema K.J., Mao H.Q. The effect of nanofiber-guided cell alignment on the preferential differentiation of neural stem cells. Biomaterials 2010, 31:9031-9039.
137. Du J., Tan E., Kim H.J., Zhang A., Bhattacharya R., Yarema K.J. Comparative evaluation of chitosan, cellulose acetate, and polyethersulfone nanofiber scaffolds for neural differentiation. Carbohydr Polym 2014, 99:483-490.
138. Prabhakaran M.P., Ghasemi-Mobarakeh L., Jin G., Ramakrishna S. Electrospun conducting polymer nanofibers and electrical stimulation of nerve stem cells. J Biosci Bioeng 2011, 112:501-507.
139. Xu X.Y., Li X.T., Peng S.W., Xiao J.F., Liu C., Fang G., et al. The behaviour of neural stem cells on polyhydroxyalkanoate nanofiber scaffolds. Biomaterials 2010, 31:3967-3975.
140. Li W., Guo Y., Wang H., Shi D., Liang C., Ye Z., et al. Electrospun nanofibers immobilized with collagen for neural stem cells culture. J Mater Sci Mater Med 2008, 19:847-854.
141. Horne M.K., Nisbet D.R., Forsythe J.S., Parish C.L. Three-dimensional nanofibrous scaffolds incorporating immobilized BDNF promote proliferation and differentiation of cortical neural stem cells. Stem Cells Dev 2010, 19:843-852.
142. Silva G.A., Czeisler C., Niece K.L., Beniash E., Harrington D.A., Kessler J.A., et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004, 303:1352-1355.
143. Callahan L.A., Xie S., Barker I.A., Zheng J., Reneker D.H., Dove A.P., et al. Directed differentiation and neurite extension of mouse embryonic stem cell on aligned poly(lactide) nanofibers functionalized with YIGSR peptide. Biomaterials 2013, 34:9089-9095.
144. Kabiri M., Soleimani M., Shabani I., Futrega K., Ghaemi N., Ahvaz H.H., et al. Neural differentiation of mouse embryonic stem cells on conductive nanofiber scaffolds. Biotechnol Lett 2012, 34:1357-1365.
145. Wang J., Ye R., Wei Y., Wang H., Xu X., Zhang F., et al. The effects of electrospun TSF nanofiber diameter and alignment on neuronal differentiation of human embryonic stem cells. J Biomed Mater Res A 2012, 100:632-645.
146. Salata O. Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2004, 2:3. 10.1186/1477-3155-2-3.
147. Kiriyama A., Iga K., Shibata N. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery. Ther Deliv 2013, 4:1261-1278.
148. Xiong M.H., Bao Y., Yang X.Z., Zhu Y.H., Wang J. Delivery of antibiotics with polymeric particles. Adv Drug Deliv Rev 2014, 78:63-76.
149. de Morais M.G., Martins V.G., Steffens D., Pranke P., da Costa J.A. Biological applications of nanobiotechnology. J Nanosci Nanotechnol 2014, 14:1007-1017.
150. Mohtaram N.K., Montgomery A., Willerth S.M. Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors. Biomed Mater 2013, 8:022001. 10.1088/1748-6041/8/2/022001.
151. Marti M.E., Sharma A.D., Sakaguchi D.S., Mallapragada S.K. 10 - Nanomaterials for neural tissue engineering. Nanomaterials in Tissue Engineering 2013, 275-301. Woodhead Publishing. A.K. Gaharwar, S. Sant, M.J. Hancock, S.A. Hacking (Eds.).
152. Ito A., Takizawa Y., Honda H., Hata K.I., Kagami H., Ueda M., et al. Tissue engineering using magnetite nanoparticles and magnetic force: Heterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng 2004, 10:833-840.
153. Ito A., Kamihira M. Tissue Engineering Using Magnetite Nanoparticles. Nanoparticles Transl Sci Med 2011, 104:355-395.
154. Lui C.N., Tsui Y.P., Ho A.S., Shum D.K., Chan Y.S., Wu C.T., et al. Neural stem cells harvested from live brains by antibody-conjugated magnetic nanoparticles. Angew Chem Int Ed Engl 2013, 52:12298-12302.
155. Cheng Y., Morshed R., Cheng S.H., Tobias A., Auffinger B., Wainwright D.A., et al. Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy. Small 2013, 9:4123-4129.
156. Amemori T., Romanyuk N., Jendelova P., Herynek V., Turnovcova K., Prochazka P., et al. Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. Stem Cell Res Ther 2013, 4:68. 10.1186/scrt219.
157. Santos T., Ferreira R., Maia J., Agasse F., Xapelli S., Cortes L., et al. Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain. ACS Nano 2012, 6:10463-10474.
158. Li X., Liu X., Zhao W., Wen X., Zhang N. Manipulating neural-stem-cell mobilization and migration in vitro. Acta Biomater 2012, 8:2087-2095.
159. Liu X., Ren X., Deng X., Huo Y., Xie J., Huang H., et al. A protein interaction network for the analysis of the neuronal differentiation of neural stem cells in response to titanium dioxide nanoparticles. Biomaterials 2010, 31:3063-3070.
160. Harrison B.S., Atala A. Carbon nanotube applications for tissue engineering. Biomaterials 2007, 28:344-353.
161. Liu Z., Tabakman S., Welsher K., Dai H. Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery. Nano Res 2009, 2:85-120.
162. Heister E., Brunner E.W., Dieckmann G.R., Jurewicz I., Dalton A.B. Are carbon nanotubes a natural solution? Applications in biology and medicine. ACS Appl Mater Interfaces 2013, 5:1870-1891.
163. Prasek J., Drbohlavova J., Chomoucka J., Hubalek J., Jasek O., Adam V., et al. Methods for carbon nanotubes synthesis-review. J Mater Chem 2011, 21:15872-15884.
164. Liu F., Zhang X.B., Cheng J.P., Tu J.P., Kong F.Z., Huang W.Z., et al. Preparation of short carbon nanotubes by mechanical ball milling and their hydrogen adsorption behavior. Carbon 2003, 41:2527-2532.
165. Huang Y.J., Wu H.C., Tai N.H., Wang T.W. Carbon nanotube rope with electrical stimulation promotes the differentiation and maturity of neural stem cells. Small 2012, 8:2869-2877.
166. Moon S.U., Kim J., Bokara K.K., Kim J.Y., Khang D., Webster T.J., et al. Carbon nanotubes impregnated with subventricular zone neural progenitor cells promotes recovery from stroke. Int J Nanomedicine 2012, 7:2751-2765.
167. Park S.Y., Choi D.S., Jin H.J., Park J., Byun K.E., Lee K.B., et al. Polarization-Controlled Differentiation of Human Neural Stem Cells Using Synergistic Cues from the Patterns of Carbon Nanotube Monolayer Coating. ACS Nano 2011, 5:4704-4711.
168. Jan E., Kotov N.A. Successful differentiation of mouse neural stem cells on layer-by-layer assembled single-walled carbon nanotube composite. Nano Lett 2007, 7:1123-1128.
169. Qi L., Li N., Huang R., Song Q., Wang L., Zhang Q., et al. The effects of topographical patterns and sizes on neural stem cell behavior. PLoS One 2013, 8:e59022. 10.1371/journal.pone.0059022.
170. McNamara L.E., McMurray R.J., Biggs M.J., Kantawong F., Oreffo R.O., Dalby M.J. Nanotopographical control of stem cell differentiation. J Tissue Eng 2010, 2010:120623. 10.4061/2010/120623.
171. Yang K., Jung K., Ko E., Kim J., Park K.I., Cho S.W. Nanotopographical manipulation of focal adhesion formation for enhanced differentiation of human neural stem cells. ACS Appl Mater Interfaces 2013, 5:10529-10540.
172. Taylor-Pashow K.M., Della Rocca J., Huxford R.C., Lin W. Hybrid nanomaterials for biomedical applications. Chem Commun (Camb) 2010, 46:5832-5849.
173. Li H., Song S.I., Song G.Y., Kim I. Non-covalently functionalized carbon nanostructures for synthesizing carbon-based hybrid nanomaterials. J Nanosci Nanotechnol 2014, 14:1425-1440.
174. Della Rocca J., Liu D., Lin W. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. Acc Chem Res 2011, 44:957-968.
175. He C., Lu K., Liu D., Lin W. Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells. J Am Chem Soc 2014, 136:5181-5184.
176. Huxford R.C., Della Rocca J., Lin W.B. Metal-organic frameworks as potential drug carriers. Curr Opin Chem Biol 2010, 14:262-268.
177. Lai C.Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 2003, 125:4451-4459.
178. Allen T.M., Cullis P.R. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013, 65:36-48.
179. Park H.Y., Noh E.H., Chung H.M., Kang M.J., Kim E.Y., Park S.P. Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection. PLoS One 2012, 7. 10.1371/journal.pone.0045812.
180. Madeira C., Mendes R.D., Ribeiro S.C., Boura J.S., Aires-Barros M.R., da Silva C.L., et al. Nonviral Gene Delivery to Mesenchymal Stem Cells Using Cationic Liposomes for Gene and Cell Therapy. J Biomed Biotechnol 2010, 10.1155/2010/735349.
181. Lee S., Ashizawa A.T., Kim K.S., Falk D.J., Notterpek L. Liposomes to Target Peripheral Neurons and Schwann Cells. PLoS One 2013, 8. 10.1371/journal.pone.0078724.
182. Begley D.J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 2004, 104:29-45.
183. Pinzon-Daza M.L., Campia I., Kopecka J., Garzon R., Ghigo D., Riganti C. Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier. Curr Drug Metab 2013, 14:625-640.
184. Gillies E.R., Frechet J.M. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005, 10:35-43.
185. Kesharwani P., Jain K., Jain N.K. Dendrimer as nanocarrier for drug delivery. Prog Polym Sci 2014, 39:268-307.
186. Benseny-Cases N., Klementieva O., Cladera J. Dendrimers antiamyloidogenic potential in neurodegenerative diseases. New J Chem 2012, 36:211-216.
187. Šebestík J., Reiniš M., Ježek J. Dendrimers in Neurodegenerative Diseases Biomedical Applications of Peptide-, Glyco- and Glycopeptide Dendrimers, and Analogous Dendrimeric Structures 2012, 209-221. Springer, Vienna.
188. Xu W., Ling P., Zhang T. Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013, 2013:340315. 10.1155/2013/340315.
189. Gaucher G., Dufresne M.H., Sant V.P., Kang N., Maysinger D., Leroux J.C. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 2005, 109:169-188.
190. Onoue S., Yamada S., Chan H.K. Nanodrugs: pharmacokinetics and safety. Int J Nanomedicine 2014, 9:1025-1037.
191. Weissig V., Pettinger T.K., Murdock N. Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine 2014, 9:4357-4373.
192. Uchegbu I.F., Siew A. Nanomedicines and nanodiagnostics come of age. J Pharm Sci 2013, 102:305-310.